Venus Remedies

Industry calls Union Budget 2026 a defining moment for India’s biopharma future

Read more

Venus Remedies receives second PLI incentive disbursement, reinforcing manufacturing strength

Read more

Venus Remedies secures Marketing Authorization for Ceftazidime + Avibactam in Indonesia

Read more

Advanced excipients could emerge as India’s next big pharma advantage

Read more

Venus Remedies’ Methotrexate, Cefuroxime, and Irinotecan enters Vietnam

Read more

Venus Remedies launches Venus Global Fulfillment Center to enhance global supply chain

Read more

Driving innovation in India’s pharma R&D through cell and gene therapy

Read more

Venus Remedies secures WHO GDP endorsement for pharma logistics

Read more

Venus Remedies secures Ukrainian GMP renewal

Read more

Venus Remedies joins United Nations Global Compact

Read more